Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer
Clinical trial NCT00629278 · UNKNOWN
Trial details
- NCT number
- NCT00629278
- Sponsor
- Azienda Ospedaliero-Universitaria di Modena
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-12-01
- Enrollment
- 2500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.